Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Silo Pharma, Inc. (SILO) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.02M |
|
$-1.03M |
|
$0.00M |
|
$0.02M |
|
$1.11M |
|
$-1.09M |
|
$0.06M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.09M |
|
$-1.09M |
|
4.48M |
|
4.48M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$5.60M |
|
-- |
|
$0.30M |
|
$5.90M |
|
$1.19M |
|
-- |
|
$0.70M |
|
$1.89M |
|
$4.01M |
|
$3.77M |
|
$4.01M |
|
4.48M |
|
| Cash Flow Statement Financials | |
$-1.64M |
|
$0.87M |
|
-- |
|
$3.91M |
|
$3.14M |
|
$-0.77M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.73 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
91.90% |
|
-6069.68% |
|
-6069.68% |
|
-- |
|
-5721.94% |
|
-5721.94% |
|
$-1.64M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-25.71% |
|
-27.34% |
|
-17.48% |
|
-25.71% |
|
$0.89 |
|
$-0.37 |
|
$-0.37 |
|